US healthcare lobbyists outspend other pressure groupsBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7443.786-c (Published 01 April 2004) Cite this as: BMJ 2004;328:786
- Janice Hopkins Tanne
- New York
Healthcare lobbyists spent $237m (£130m; £195m), more than any other industry, to influence US senators and representatives, the White House, and federal agencies in 2000, says an article in the American Journal of Medicine (2004;116:474-7).
Drug companies and medical supply companies together spent $96m. Physicians and other health professionals, such as nurses, spent $46m, hospitals and nursing homes $40m, health insurance and managed care companies $31m, and disease advocacy and public health organisations spent $12m. During the study period, 1997-2000, spending on lobbying by health professionals grew by only 10% compared with 26% by other organisations.
An editorial in the same …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial